Authors:
Burtness, B
Belker, M
Stoltz, M
Peccerillo, KM
Lamb, LA
Chmael, SE
McKeon, A
Clark, MB
Winship, J
Marsh, JC
Pizzorno, G
DeVita, VT
Citation: B. Burtness et al., A phase I study of the antimetabolite (E)-2 '-fluoromethylene-2 '-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion, CANCER J, 6(5), 2000, pp. 309-315
Citation: Na. Marshall et Vt. Devita, Hodgkin's disease and transplantation: A room with a (nontransplanter's) view, SEMIN ONCOL, 26(1), 1999, pp. 67-73